| 05/14/2026 7:00 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/19/2026 3:15 PM | Biofrontera (1858685) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/19/2026 8:35 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 8:20 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/06/2026 8:25 PM | Biofrontera (1858685) Issuer BORER JOHN J III (1406217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 8:26 PM | Biofrontera (1858685) Issuer Jones George Patrick (2085560) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 8:28 PM | Biofrontera (1858685) Issuer Hoffman Beth J. (1885321) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 8:29 PM | Biofrontera (1858685) Issuer Lanckriet Heikki (1990267) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 8:30 PM | Biofrontera (1858685) Issuer Leffler Eugene Frederick (1952347) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 8:31 PM | Biofrontera (1858685) Issuer Luebbert Hermann (1886492) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 8:33 PM | Biofrontera (1858685) Issuer Weber Kevin Daniel (1916746) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BFRIW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/26/2026 8:20 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 10:31 AM | Biofrontera (1858685) Subject Rosalind Advisors, Inc. (1622627) Filed by | Form SCHEDULE 13G/A | |
| 02/09/2026 8:20 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/28/2026 1:10 PM | Biofrontera (1858685) Subject HIRSCHMAN ORIN (1131362) Filed by | Form SCHEDULE 13G/A | |
| 01/13/2026 7:35 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 3:30 PM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/21/2025 11:15 PM | Biofrontera (1858685) Filer | Form EFFECT | |
| 12/05/2025 4:15 PM | Biofrontera (1858685) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 11/13/2025 7:30 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 3:31 PM | Biofrontera (1858685) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 1:52 PM | Biofrontera (1858685) Subject Rosalind Advisors, Inc. (1622627) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 7:05 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 4:29 PM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/23/2025 7:50 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 7:53 AM | Biofrontera (1858685) Issuer Link Christian Alexander Ansgar (2088822) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/30/2025 7:42 AM | Biofrontera (1858685) Issuer DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT (1571070) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/30/2025 7:47 AM | Biofrontera (1858685) Issuer VV Beteiligungen Aktiengesellschaft (1571058) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/30/2025 7:35 AM | Biofrontera (1858685) Issuer Plaggemars Hansjoerg (2088823) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/26/2025 3:49 PM | Biofrontera (1858685) Issuer DEUTSCHE BALATON AKTIENGESELLSCHAFT (1571071) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/26/2025 3:59 PM | Biofrontera (1858685) Issuer Zours Wilhelm Konrad Thomas (1571015) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/25/2025 2:23 PM | Biofrontera (1858685) Issuer de la Huerta Martinez Maria del Pilar (2084869) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/19/2025 3:45 PM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/19/2025 2:04 PM | Biofrontera (1858685) Subject DEUTSCHE BALATON AKTIENGESELLSCHAFT (1571071) Filed by | Form SCHEDULE 13D/A | |
| 09/18/2025 10:59 AM | Biofrontera AG (1712641) Reporting Biofrontera (1858685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 8:19 PM | Biofrontera (1858685) Issuer Leffler Eugene Frederick (1952347) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 8:21 PM | Biofrontera (1858685) Issuer Luebbert Hermann (1886492) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 8:22 PM | Biofrontera (1858685) Issuer Weber Kevin Daniel (1916746) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 8:23 PM | Biofrontera (1858685) Issuer Jones George Patrick (2085560) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/16/2025 8:25 PM | Biofrontera (1858685) Issuer Jones George Patrick (2085560) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 8:15 PM | Biofrontera (1858685) Issuer BORER JOHN J III (1406217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
June 12: $100 Turns Into $100,000? (Ad) The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast.
Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears. Click here to see how to get ahead of the SpaceX IPO |
| 09/16/2025 8:17 PM | Biofrontera (1858685) Issuer Hoffman Beth J. (1885321) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 8:18 PM | Biofrontera (1858685) Issuer Lanckriet Heikki (1990267) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2025 11:15 PM | Biofrontera (1858685) Filer | Form EFFECT | |
| 08/13/2025 4:22 PM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 4:30 PM | Biofrontera (1858685) Filer | Form S-1/A | |
| 08/11/2025 4:10 PM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/11/2025 12:57 PM | Biofrontera (1858685) Subject Rosalind Advisors, Inc. (1622627) Filed by | Form SCHEDULE 13G/A | |
| 07/25/2025 1:31 PM | Biofrontera (1858685) Subject DEUTSCHE BALATON AKTIENGESELLSCHAFT (1571071) Filed by | Form SCHEDULE 13D/A | |
| 07/16/2025 4:28 PM | Biofrontera (1858685) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 07/11/2025 4:21 PM | Biofrontera (1858685) Filer | Form D Notice of Exempt Offering of Securities | |
| 07/09/2025 1:56 PM | Biofrontera AG (1712641) Reporting Biofrontera (1858685) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/01/2025 7:55 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/30/2025 7:05 AM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2025 3:15 PM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/11/2025 2:00 PM | Biofrontera (1858685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |